Ingalls & Snyder LLC Eli Lilly & CO Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

A detailed history of Ingalls & Snyder LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ingalls & Snyder LLC holds 7,002 shares of LLY stock, worth $5.25 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

7,002

Previous 7,322 4.37%

Holding current value

$5.25 Million

Previous $6.63 Million 6.43%

% of portfolio

0.24%

Previous 0.28%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $247,084 - $307,206	-320 Reduced 4.37%	7,002 $6.2 Million
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $147,148 - $184,535	-203 Reduced 2.7%	7,322 $6.63 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $503,962 - $674,230	-851 Reduced 10.16%	7,525 $5.85 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $659,113 - $777,008	-1,255 Reduced 13.03%	8,376 $4.88 Million
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $556,416 - $767,104	1,280 Added 15.33%	9,631 $5.17 Million
Q2 2023 Jul 27, 2023	SELL	$350.74 - $468.98 $1.16 Million - $1.55 Million	-3,303 Reduced 28.34%	8,351 $3.92 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $23,607 - $27,726	-76 Reduced 0.65%	11,654 $4 Million
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $16,077 - $18,733	-50 Reduced 0.42%	11,730 $4.29 Million
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $37,356 - $42,571	-126 Reduced 1.06%	11,780 $3.81 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $32,053 - $37,636	115 Added 0.98%	11,906 $3.86 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $687,172 - $853,980	-2,928 Reduced 19.89%	11,791 $3.38 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $102,306 - $126,963	-455 Reduced 3.0%	14,719 $4.07 Million
Q3 2021 Oct 27, 2021	SELL	$221.6 - $272.71 $49,860 - $61,359	-225 Reduced 1.46%	15,174 $3.51 Million
Q2 2021 Aug 03, 2021	SELL	$180.55 - $233.54 $22,568 - $29,192	-125 Reduced 0.81%	15,399 $3.53 Million
Q1 2021 Apr 21, 2021	SELL	$164.32 - $212.72 $100,728 - $130,397	-613 Reduced 3.8%	15,524 $2.9 Million
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $54,010 - $71,468	414 Added 2.63%	16,137 $2.73 Million
Q3 2020 Oct 21, 2020	BUY	$146.22 - $169.13 $6,579 - $7,610	45 Added 0.29%	15,723 $2.33 Million
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $66,163 - $79,627	-485 Reduced 3.0%	15,678 $2.57 Million
Q1 2020 Apr 22, 2020	SELL	$119.05 - $147.35 $126,669 - $156,780	-1,064 Reduced 6.18%	16,163 $2.24 Million
Q4 2019 Jan 15, 2020	BUY	$106.92 - $132.43 $136,323 - $168,848	1,275 Added 7.99%	17,227 $2.26 Million
Q2 2019 Jul 11, 2019	BUY	$110.79 - $129.32 $94,171 - $109,922	850 Added 5.63%	15,952 $1.77 Million
Q1 2019 Apr 11, 2019	SELL	$111.31 - $131.02 $5,565 - $6,551	-50 Reduced 0.33%	15,102 $1.96 Million
Q4 2018 Jan 24, 2019	SELL	$105.9 - $118.64 $344,175 - $385,580	-3,250 Reduced 17.66%	15,152 $1.75 Million
Q1 2018 Apr 17, 2018	SELL	$74.21 - $87.6 $21,520 - $25,404	-290 Reduced 1.55%	18,402 $1.42 Million
Q4 2017 Jan 19, 2018	BUY	$81.94 - $87.89 $5,735 - $6,152	70 Added 0.38%	18,692 $1.58 Million
Q3 2017 Oct 20, 2017	BUY	$77.07 - $85.54 $1.44 Million - $1.59 Million	18,622	18,622 $1.59 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Eli Lilly & CO Transaction History